More recently, a positive correlation between sFasL levels in the plasma of COVID-19 patients with lymphopenia, CD4+ T susceptibility to apoptosis and disease severity was reported, suggesting that FasL might be involved in the lymphopenia characteristic of COVID-19 and could be a marker for COVID-19 severity [25–27]. The gene discussed is FASLG; the disease is COVID-19.